MLchartDataset catalogue

RECIST

Term · Oncology and biomedicine · MLC-T-ONC-007248

A standard way to measure how well a cancer patient responds to treatment. It is based on whether tumors shrink, stay the same, or get bigger. To use RECIST, there must be at least one tumor that can be measured on x-rays, CT scans, or MRI scans. The types of response a patient can have are a complete response (CR), a partial response (PR), progressive disease (PD), and stable disease (SD). Also called Response Evaluation Criteria In Solid Tumors.

Table 1. Record
IdentifierMLC-T-ONC-007248
FieldOncology and biomedicine
ExpansionsResponse Evaluation Criteria In Solid Tumors
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007248",
  "term": "RECIST",
  "field": "Oncology and biomedicine",
  "definition": "A standard way to measure how well a cancer patient responds to treatment. It is based on whether tumors shrink, stay the same, or get bigger. To use RECIST, there must be at least one tumor that can be measured on x-rays, CT scans, or MRI scans. The types of response a patient can have are a complete response (CR), a partial response (PR), progressive disease (PD), and stable disease (SD). Also called Response Evaluation Criteria In Solid Tumors.",
  "expansions": [
    "Response Evaluation Criteria In Solid Tumors"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/recist/"
}

Record 14,121 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.